Averting a malaria disaster

As treatments loose their effectiveness, morbidity and mortality from malaria will inevitably continue to rise. The rationale for combining drugs with independent modes of action is examined.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) Jg. 353; H. 9168; S. 1965 - 1967
Hauptverfasser: White, NJ, Nosten, F, Looareesuwan, S, Watkins, WM, Marsh, K, Snow, RW, Kokwaro, G, Ouma, J, Hien, TT, Molyneux, ME, Taylor, TE, Newbold, CI, Ruebush, TK, Danis, M, Greenwood, BM, Anderson, RM, Olliaro, P
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Elsevier Ltd 05.06.1999
Lancet
Elsevier Limited
Schlagworte:
Animals
Antimalarials - economics
Antimalarials - therapeutic use
Artemisinins
Biological and medical sciences
Costs and Cost Analysis
Drug Resistance
Drug therapy
Drug Therapy, Combination
Drugs, Chinese Herbal - therapeutic use
Human protozoal diseases
Humans
Infectious diseases
Malaria
Malaria, Falciparum - drug therapy
Malaria, Falciparum - epidemiology
Malaria, Falciparum - prevention & control
Medical research
Medical sciences
Parasitic diseases
Protozoal diseases
Pyrimethamine - therapeutic use
Sesquiterpenes - therapeutic use
Sulfadoxine - therapeutic use
Tropical medicine
Vector-borne diseases
Epidemic
Human
Antimalarial
Protozoal disease
Chemoprophylaxis
Costs
Malaria
Toxicity
Artemisinin
Parasitosis
Infection
Prevention
Resistance
Treatment
Parasiticid
ISSN:0140-6736, 1474-547X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:As treatments loose their effectiveness, morbidity and mortality from malaria will inevitably continue to rise. The rationale for combining drugs with independent modes of action is examined.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(98)07367-X